Newly Established Generic Pharmaceuticals Company Investment Opportunity in Dhaka, Bangladesh

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management.

- The brand, licenses, registrations, client base, and property have been transferred to the new owners.

- Was supplying across Bangladesh, the Middle East, and African countries under its own branding.

- The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production.

- With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution.

- The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs.

- Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc.

- The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets.

- Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success.

- The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization.

- Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand.

- Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- Pharma manufacturing business with B2B model - supplying to wholesalers, pharmacies, hospitals, clinics, and distributors across Bangladesh, the Middle East, and African countries under own branding.

- Drug formulations manufactured include liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs.

- Drug categories are antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc.

Physical assets include the acquired manufacturing property, land and machinery.

Acquired pharma manufacturing facility which is a 10,000 sq ft property and land - 24.4 decimal.

A 6-storied building, located in Milk Vita Road, Dhaka.

Business is self-funded.

Having outstanding bank loans of BDT 70Cr.

There are 3 partners currently.